Host APCs augment in vivo expansion of donor natural regulatory T cells via B7H1/B7.1 in allogeneic recipients.
Foxp3(+) regulatory T (Treg) cells include thymic-derived natural Treg and conventional T-derived adaptive Treg cells. Both are proposed to play important roles in downregulating inflammatory immune responses. However, the mechanisms of Treg expansion in inflammatory environments remain unclear. In this study, we report that, in an autoimmune-like graft-versus-host disease model of DBA/2 (H-2(d)) donor to BALB/c (H-2(d)) recipients, donor Treg cells in the recipients predominantly originated from expansion of natural Treg cells and few originated from adaptive Treg cells. In vivo neutralization of IFN-γ resulted in a marked reduction of donor natural Treg expansion and exacerbation of graft-versus-host disease, which was associated with downregulation of host APC expression of B7H1. Furthermore, host APC expression of B7H1 was shown to augment donor Treg survival and expansion. Finally, donor Treg interactions with host APCs via B7.1/B7H1 but not PD-1/B7H1 were demonstrated to be critical in augmenting donor Treg survival and expansion. These studies have revealed a new immune regulation loop consisting of T cell-derived IFN-γ, B7H1 expression by APCs, and B7.1 expression by Treg cells.
Irell & Manella Graduate School of Biological Sciences, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA 91010, USA.
Tangsheng
T
Yi
Xiaofan
X
Li
Sheng
S
Yao
Lin
L
Wang
Yuhong
Y
Chen
Dongchang
D
Zhao
Heather F
HF
Johnston
James S
JS
Young
Hongjun
H
Liu
Ivan
I
Todorov
Stephen J
SJ
Forman
Lieping
L
Chen
Defu
D
Zeng
D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D000954:Antigens, Surface / Q000096:biosynthesis / Q000502:physiology*; D051017:Apoptosis Regulatory Proteins / Q000096:biosynthesis / Q000502:physiology*; D001327:Autoimmune Diseases / Q000235:genetics / Q000276:immunology / Q000473:pathology; D018122:B7-1 Antigen / Q000096:biosynthesis / Q000502:physiology*; D060890:B7-H1 Antigen; D002454:Cell Differentiation / Q000235:genetics / Q000276:immunology*; D004195:Disease Models, Animal; D006086:Graft vs Host Disease / Q000235:genetics / Q000276:immunology / Q000473:pathology; D007113:Immunity, Innate / Q000235:genetics; D060945:Inducible T-Cell Co-Stimulator Ligand; D007371:Interferon-gamma / Q000037:antagonists & inhibitors / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000502:physiology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D018345:Mice, Knockout; D010455:Peptides / Q000037:antagonists & inhibitors / Q000502:physiology*; D061026:Programmed Cell Death 1 Receptor; D050378:T-Lymphocytes, Regulatory / Q000276:immunology* / Q000378:metabolism / Q000473:pathology
D000954:Antigens, Surface; D051017:Apoptosis Regulatory Proteins; D018122:B7-1 Antigen; D060890:B7-H1 Antigen; C498919:Cd274 protein, mouse; D060945:Inducible T-Cell Co-Stimulator Ligand; D008562:Membrane Glycoproteins; C491383:Pdcd1 protein, mouse; D010455:Peptides; D061026:Programmed Cell Death 1 Receptor; D007371:Interferon-gamma
Blood. 2008 Sep 1;112(5):2101-10
18596226
J Immunol. 2001 Aug 1;167(3):1821-9
11466408
Blood. 2007 Aug 1;110(3):1064-72
17449800
J Immunol. 1988 Apr 1;140(7):2121-7
3127461
Nat Rev Immunol. 2004 May;4(5):336-47
15122199
J Exp Med. 2001 Jun 4;193(11):1311-8
11390438
Science. 1999 Jul 16;285(5426):412-5
10411505
Blood. 2010 Aug 26;116(8):1291-8
20472828
Immunity. 2007 Jul;27(1):111-22
17629517
J Exp Med. 2002 Aug 5;196(3):389-99
12163567
Biol Blood Marrow Transplant. 2007 Jan;13(1):46-55
17222752
J Immunol. 2003 Aug 1;171(3):1272-7
12874215
Blood. 2006 Apr 1;107(7):2993-3001
16352808
J Immunol. 2011 Jan 15;186(2):856-68
21149609
Nat Med. 2003 Sep;9(9):1144-50
12925844
Annu Rev Immunol. 2008;26:677-704
18173375
Eur J Immunol. 2005 Sep;35(9):2598-607
16078276
Hepatology. 2008 Nov;48(5):1632-43
18972444
Blood. 2008 Sep 1;112(5):2129-38
18550852
Nat Immunol. 2010 Dec;11(12):1093-101
20953201
Blood. 2007 Mar 15;109(6):2649-56
17095616
J Exp Med. 2007 Aug 6;204(8):1775-85
17620362
Blood. 2007 Nov 15;110(10):3804-13
17693581
J Exp Med. 2005 Jun 20;201(12):1925-35
15967822
J Exp Med. 2004 Jan 5;199(1):25-34
14699080
J Immunol. 2009 Jan 15;182(2):766-73
19124719
Annu Rev Immunol. 2007;25:139-70
17129175
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10691-6
15249675
J Exp Med. 2005 Nov 21;202(10):1375-86
16287710
Nat Immunol. 2007 Apr;8(4):345-50
17375096
Arthritis Res Ther. 2005;7(2):R402-15
15743488
J Immunol. 2006 Sep 1;177(5):2948-58
16920930
J Exp Med. 2007 Sep 3;204(9):2039-45
17724131
J Immunol. 2004 May 1;172(9):5213-21
15100259
J Immunol. 1996 Oct 15;157(8):3250-9
8871619
Science. 2007 Jul 13;317(5835):256-60
17569825
Nat Med. 2002 Jun;8(6):575-81
12042807
Nat Med. 1999 Dec;5(12):1365-9
10581077
Blood. 2009 Oct 1;114(14):3101-12
19602708
J Exp Med. 2003 Dec 15;198(12):1875-86
14676299
Microbes Infect. 2009 Apr;11(5):612-9
19375514
Nat Rev Immunol. 2003 Mar;3(3):253-7
12658273
Cancer Res. 2005 Feb 1;65(3):1089-96
15705911
Blood. 2009 Jan 22;113(4):953-62
18922852
J Exp Med. 2007 Aug 6;204(8):1757-64
17620361
Immunity. 2004 Mar;20(3):327-36
15030776
J Exp Med. 2009 Dec 21;206(13):3015-29
20008522
Nature. 2007 Nov 22;450(7169):566-9
18033300
Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9331-6
18599457
J Clin Invest. 2009 Mar;119(3):551-64
19229109
Blood. 2009 Sep 3;114(10):2149-58
19597183